Supplementary Data from Cancer-Associated MORC2-Mutant M276I Regulates an Hnrnpm-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer

Fang-Lin Zhang,Jin-Ling Cao,Hong-Yan Xie,Rui Sun,Li-Feng Yang,Zhi-Ming Shao,Da-Qiang Li

DOI: https://doi.org/10.1158/0008-5472.22417398.v1

2023-01-01

Abstract:The supplementary information includes 9 supplementary Figures and 8 supplementary tables: Figure S1. Analysis of MORC2 mutational frequency in human cancer from the cBioPortal for Cancer Genomics database. Figure S2. Analysis of MORC2 mutational frequency in various types of human cancer in the COSMIC database. Figure S3. The mutational patterns of MORC2 in breast cancer. Figure S4. Clinical information of the TNBC patient harboring the M276I mutation. Figure S5. Detection of the MORC2 M276I mutation in TNBC cell lines by targeted exon sequencing. Figure S6. Schematic representation of the structural domains of human MORC2 protein. Figure S7. The M276I mutation does not affect cell proliferation and cell-cycle progression. Figure S8. The M276I mutation enhances migratory and invasive potential of TNBC cells. Figure S9. Both WT and M276I mutant MORC2 do not interact with hnRNPA1 and hnRNPL. Table S1. Information for the expression vectors used in this study. Table S2. Primers used for molecular cloning of expression vectors. Table S3. siRNA target sequences for hnRNPL. Table S4. Primary antibodies and antibody-conjugated magnetic beads used in this study. Table S5. Primers for qPCR analysis. Table S6. Primers used for targeted exon sequencing of MORC2-M276 mutation in TNBC cell lines. Table S7. The list of 48 proteins that interact with both WT and mutant M276I MORC2. Table S8. The GO molecular functions analyses of 48 proteins that interact with both WT and mutant M276I MORC2 using the PANTHER program.